- Home
- CLLS vs INGN Comparison
CLLS vs INGN Comparison
Compare CLLS & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | INGN |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.6M | 186.8M |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CLLS | INGN |
|---|---|---|
| Price | $4.74 | $6.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.50 | ★ $11.00 |
| AVG Volume (30 Days) | 116.7K | ★ 149.6K |
| Earning Date | 11-07-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $82,551,000.00 | ★ $347,028,000.00 |
| Revenue This Year | $32.58 | $8.04 |
| Revenue Next Year | $20.68 | $8.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.04 | 4.68 |
| 52 Week Low | $1.10 | $5.70 |
| 52 Week High | $5.48 | $12.91 |
Technical Indicators
Market Signals| Indicator | CLLS | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 43.02 |
| Support Level | $4.47 | $6.62 |
| Resistance Level | $5.03 | $7.01 |
| Average True Range (ATR) | 0.28 | 0.19 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 52.60 | 28.28 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.